Novorapid Penfill (3ml Each) is used for blood sugar control in people with type 1 and type 2 diabetes mellitus. It is a fast-acting type of insulin that helps to lower blood sugar levels after meals and reduce the chances of developing serious complications of diabetes.
Novorapid Penfill (3ml Each) is normally prescribed along with a long-acting type of insulin or other diabetes medicines. Your doctor or nurse will teach you the correct way of injecting it under the skin. It should be taken at the start of a meal or within 20 minutes after starting a meal. Check your blood sugar levels regularly, keep track of your results and share them with your doctor. This is very important to work out the correct dose of the medicine for you.
Do not use this medicine when you have low blood sugar levels (hypoglycemia). Tell your doctor if you have ever had kidney, liver, or heart problems before starting treatment. Pregnant or breastfeeding women should also consult their doctor as the dose may need to be changed. Do not stop taking it unless your doctor tells you to. It is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor.
The most common side effects of this medicine are low blood sugar levels (hypoglycemia), headache, nasopharyngitis, and upper respiratory tract infection. To prevent this, it is important to always inject the correct dose of medicine only, have regular meals, and monitor your blood sugar levels regularly. Drinking excessive alcohol can also lead to a fall in your blood sugar levels. Other side effects include allergies at the injection site like redness, swelling, or hard lumps (lipodystrophy). Some people gain weight while taking insulin.
Medicinal Benefits
Novorapid 100IU/ml Penfill 3 ml works by ensuring rapid and consistent sugar control. Novorapid 100IU/ml Penfill 3 ml is a fast-acting form of insulin that helps lower blood sugar levels after the intake of food. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses sugar production in the liver. Novorapid 100IU/ml Penfill 3 ml helps in improving the glycaemic control, which in turn decreases the risk of progression of complications of diabetes like damage to the retina (retinopathy), damage to the kidney (nephropathy), impairment of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer and others. Besides this, Novorapid 100IU/ml Penfill 3 ml can be safely prescribed to the diabetic mother during pregnancy and lactation.
Directions for Use
Novorapid 100IU/ml Penfill 3 ml is administered 5-10 minutes before taking meal subcutaneously (SC) in the abdomen or thigh region. It can be also given intravenously (IV) with 0.9% sodium chloride infusion. However subcutaneous injection of Novorapid 100IU/ml Penfill 3 ml in the abdomen region ensures faster absorption compared to other injection sites. Novorapid 100IU/ml Penfill 3 ml is usually given once or twice daily when both rapid and prolonged effect of insulin is desired. In the initial requirement, the dose requirement is usually between 0.3 and 1.0 IU/kg per day. An injection of Novorapid 100IU/ml Penfill 3 ml should be followed within 30 minutes by a meal or snack containing sugar/glucose (carbohydrates). If you are not well trained to self-administer Novorapid 100IU/ml Penfill 3 ml, ask healthcare professional to administer it.Procedure for self-injecting insulin:•You should wash your hand first before injecting insulin.•Then roll the insulin bottle and wipe the bottle top.•Now pull the plunger of the syringe down to an appropriate number of units your doctor has prescribed.•Push the needle into the bottle and push syringe plunger down.•Now once again pull the plunger down to an appropriate number of units as prescribed by the doctor.•Pick the injection site and wipe it with an alcohol swab. Now, pinch up the skin and push the needle into the skin and then push the plunger in.•The needle should be kept under the skin for at least 6 seconds to make sure the entire dose is injected.•After injecting the insulin pull out the needle and dispose of the syringe safely. And then you can have a meal or snack.
HOW NOVORAPID SOLUTION FOR INJECTION WORKS
Novorapid Penfill (3ml Each) is fast-acting insulin. It starts working within 10-20 minutes after injection. It works like your body’s natural insulin. Insulin facilitates reuptake of glucose in muscles and fat cells and also blocks the release of glucose from the liver.
Drug Warnings
Novorapid 100IU/ml Penfill 3 ml is for subcutaneous (under the skin) use only and should never be administered intravenously (IV) or in the veins. If you are changing the brand of insulin or if you need to inject your insulin by another method, it should be done under strict medical supervision. Cases of heart failure were reported when pioglitazone was used with insulin, especially in patients at high risk of cardiac heart failure. The first symptoms of hyperglycaemia (high blood sugar level) may include symptoms like excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite and acetone odour of the breath. You should closely monitor these symptoms. Symptoms like heart failure, weight gain and oedema (fluid deposition in tissue) should not be overruled. It is advisable not to consume alcohol as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. Novorapid 100IU/ml Penfill 3 ml may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma and even death. Do not take Novorapid 100IU/ml Penfill 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs.
Disclaimer
The product information contained herein is for informational purposes only, and is not intended to diagnose, treat, or prevent any disease or health condition. Pharmville Pharmacy does not endorse the appropriateness or reliability of this information and is not responsible if the content is not accurate, complete or current. Your use of this information is entirely at your own risk, and in no event shall Pharmville Pharmacy be liable for any loss or damage arising out of, or in connection with, the use of this material.
